Increased PD-L1 expression in KRAS mutated premalignant human bronchial epithelial cells is enhanced by LKB1 loss and mediated by ERK activation

Lignende værker

• FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells
  af: Lee, Mi-Heon, et al.
  Udgivet: (2020)
• Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway
  af: Lee, Mi-Heon, et al.
  Udgivet: (2014)
• The immune contexture associates with the genomic landscape in lung adenomatous premalignancy
  af: Krysan, Kostyantyn, et al.
  Udgivet: (2019)
• Loss of miR-125a expression in a model of K-ras-dependent pulmonary premalignancy
  af: Liclican, Elvira L., et al.
  Udgivet: (2014)
• IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
  af: Kachroo, Puja, et al.
  Udgivet: (2013)